<DOC>
	<DOCNO>NCT02485678</DOCNO>
	<brief_summary>Comparison number ER plus hospital visit occur chemotherapy telephone intervention control arm .</brief_summary>
	<brief_title>A Pragmatic Trial Ambulatory Toxicity Management Patients Receiving Adjuvant Neo-adjuvant Chemotherapy Early Stage Breast Cancer</brief_title>
	<detailed_description>Using pragmatic cluster-randomized trial design , 20 Ontario cancer centre provide care patient breast cancer randomly allocate one two arm : pro-active telephone toxicity management ( intervention ) , control ( routine care ) . All patient early stage ( I-III ) breast cancer commence adjuvant neo-adjuvant chemotherapy participate institution 6 12-month intervention period ( vary centre depend number incident case ) evaluate use Ontario healthcare administrative data . A sub-set least 25 patient participate institution participate PRO sub-study involve completion standardize questionnaire measure : ) severity chemotherapy treatment toxicity ; b ) self-care management chemotherapy toxicity ; c ) self-efficacy ( confidence ) managing symptom ; ) quality life ; e ) coordination care . Patients participate PRO sub-study ask provide consent link PRO data Ontario healthcare administrative data correlation symptom self-assessments Quality Life ( QoL ) measure make administrative data ED+H visit use supportive care medication . investigator compare use supportive care medication ( i.e . anti-emetics , growth factor ) patient intervention control arm assess influence severity chemotherapy-related toxicity part exploratory sub-group analysis patient &gt; 65 year age administrative data supportive care medication use available age group .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>Women 18 year age old Diagnosis early stage ( IIII ) breast cancer Starting adjuvant neoadjuvant chemotherapy within intervention period participate centre Currently participate clinical trial involve investigational agent Inclusion Criteria PRO SubStudy Willingness participate study complete PRO questionnaire require Ability understand provide write informed consent Language literacy skill consistent complete study questionnaire</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>ambulatory toxicity management</keyword>
	<keyword>adjuvant neoadjuvant chemotherapy</keyword>
</DOC>